Cardio3 BioSciences (C3BS) (Euronext Brussels and Paris: CARD), brings breaking news with yesterday’s recent announcement of a fully committed capital increase of €25M in two phases, at €44 a share, representing an approximate 14% premium to [...]
OncoDNA SA expands its territory with the recent announcement of a supplier agreement with NBCC (National Blood and Cancer Center); a specialized centre for diagnosing and treating blood diseases and cancers located in Riyadh, Saudi Arabia, [...]
As part of an expert pan-European consortium* BONE THERAPEUTICS has been awarded a share of the highly competitive Marie Curie grant1 in the amount of €3.8 million. The grant will fund a four-year project entitled BIO-INSPIRE [...]